Dr. Gena Foster | Assistant Professor of Medicine, Yale School of Medicine

For Dr. Gena Foster, medicine often begins where certainty ends.

As an Assistant Professor of Medicine at Yale School of Medicine specializing in autoimmune blood disorders, she treats patients with conditions that are frequently misunderstood, difficult to diagnose, and rapidly evolving. Many of these diseases lack clear standards of care, requiring physicians to make decisions in areas where the evidence is still emerging.

To navigate those uncertainties, Gena regularly turns to the scientific literature. Her work sits at the intersection of patient care, clinical trials, and immunology research, where understanding the biology behind a disease can be just as important as understanding the latest clinical study.

Consensus helps her move quickly between those worlds. Rather than searching through dozens of papers manually, she can investigate specific biological pathways, explore how therapies work at a mechanistic level, and rapidly evaluate evidence that may help inform both research questions and patient care decisions.

Recently, that approach proved especially valuable. Faced with a complex patient case involving competing diagnostic possibilities, Gena used Consensus to surface relevant mechanistic research and share it with colleagues across multiple specialties. The evidence helped support a critical decision to pursue additional diagnostic evaluation before moving forward with an aggressive treatment plan.

For Gena, the goal is never to replace clinical judgment. It is to strengthen it. Having fast access to the underlying science allows her to evaluate ideas more rigorously, challenge assumptions, and ensure that

important decisions are grounded in evidence rather than intuition alone.

As both a physician and researcher, Gena believes some of the most important insights come from understanding not just what works, but why it works. By making decades of scientific literature easier to explore, Consensus helps her connect emerging discoveries to the patients who need them most.